Trials / Conditions / HER2-positive Advanced Solid Tumor
HER2-positive Advanced Solid Tumor
3 registered clinical trials studyying HER2-positive Advanced Solid Tumor — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors NCT05150691 | DualityBio Inc. | Phase 1 / Phase 2 |
| Enrolling By Invitation | Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors NCT05423977 | Hangzhou Adcoris Biopharmacy Co., Ltd | Phase 1 |
| Unknown | Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors NCT04450732 | GeneQuantum Healthcare (Suzhou) Co., Ltd. | Phase 1 |